Dumaog, Junalyn R.

HRN: 24-19-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
CEFUROXIME 1.5GM (VIAL)
12/04/2023
12/11/2023
IV
1.5g
Q8hrs
Multiple Soft Tissue Injury
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: